223 related articles for article (PubMed ID: 25502723)
21. Platelets and angiogenesis in malignancy.
Sierko E; Wojtukiewicz MZ
Semin Thromb Hemost; 2004 Feb; 30(1):95-108. PubMed ID: 15034801
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model.
Byrne AT; Ross L; Holash J; Nakanishi M; Hu L; Hofmann JI; Yancopoulos GD; Jaffe RB
Clin Cancer Res; 2003 Nov; 9(15):5721-8. PubMed ID: 14654557
[TBL] [Abstract][Full Text] [Related]
23. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
[TBL] [Abstract][Full Text] [Related]
24. Expression of angiogenesis regulatory proteins and epithelial-mesenchymal transition factors in platelets of the breast cancer patients.
Han H; Cao FL; Wang BZ; Mu XR; Li GY; Wang XW
ScientificWorldJournal; 2014; 2014():878209. PubMed ID: 25379550
[TBL] [Abstract][Full Text] [Related]
25. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
26. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.
Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K
Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481
[TBL] [Abstract][Full Text] [Related]
27. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
[TBL] [Abstract][Full Text] [Related]
28. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model.
Wiener JR; Nakano K; Kruzelock RP; Bucana CD; Bast RC; Gallick GE
Clin Cancer Res; 1999 Aug; 5(8):2164-70. PubMed ID: 10473101
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas.
Ueda M; Hung YC; Terai Y; Kanda K; Kanemura M; Futakuchi H; Yamaguchi H; Akise D; Yasuda M; Ueki M
Clin Cancer Res; 2005 May; 11(9):3225-32. PubMed ID: 15867217
[TBL] [Abstract][Full Text] [Related]
30. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.
Liu X; Shen M; Qi Q; Zhang H; Guo SW
Hum Reprod; 2016 Apr; 31(4):734-49. PubMed ID: 26908845
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.
Hazelton D; Nicosia RF; Nicosia SV
Clin Cancer Res; 1999 Apr; 5(4):823-9. PubMed ID: 10213218
[TBL] [Abstract][Full Text] [Related]
32. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis.
Solanilla A; Villeneuve J; Auguste P; Hugues M; Alioum A; Lepreux S; Ducroix JP; Duhaut P; Conri C; Viallard JF; Nurden AT; Constans J; Ripoche J
Rheumatology (Oxford); 2009 Sep; 48(9):1036-44. PubMed ID: 19549789
[TBL] [Abstract][Full Text] [Related]
33. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
[TBL] [Abstract][Full Text] [Related]
34. RELATIONSHIP BETWEEN THE PROANGIOGENIC ROLE OF EG-VEGF, CLINICOPATHOLOGICAL CHARACTERISTICS AND SURVIVAL IN TUMORAL OVARY.
Lozneanu L; Avădănei R; Cîmpean AM; Giuşcă SE; Amălinei C; Căruntu ID
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):461-5. PubMed ID: 26204653
[TBL] [Abstract][Full Text] [Related]
35. Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines.
Apte SM; Bucana CD; Killion JJ; Gershenson DM; Fidler IJ
Gynecol Oncol; 2004 Apr; 93(1):78-86. PubMed ID: 15047217
[TBL] [Abstract][Full Text] [Related]
36. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
Li D; Williams JI; Pietras RJ
Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639
[TBL] [Abstract][Full Text] [Related]
37. Platelets increase the proliferation of ovarian cancer cells.
Cho MS; Bottsford-Miller J; Vasquez HG; Stone R; Zand B; Kroll MH; Sood AK; Afshar-Kharghan V
Blood; 2012 Dec; 120(24):4869-72. PubMed ID: 22966171
[TBL] [Abstract][Full Text] [Related]
38. Platelets and metastasis revisited: a novel fatty link.
Gupta GP; Massagué J
J Clin Invest; 2004 Dec; 114(12):1691-3. PubMed ID: 15599391
[TBL] [Abstract][Full Text] [Related]
39. Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression.
Swier N; Versteeg HH
Thromb Res; 2017 Feb; 150():8-18. PubMed ID: 27988375
[TBL] [Abstract][Full Text] [Related]
40. [Expression of vascular endothelial growth factor and microvessel density in ovarian tumor].
Qi SY
Ai Zheng; 2003 Mar; 22(3):320-3. PubMed ID: 12654197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
